Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC) Meeting Abstract


Authors: Wang, R.; Singh, J. C.; Wong, S. T. L.; Lake, D.; Iyengar, N. M.; D'Andrea, G.; Brockway-Marchello, J. P.; Kaba, A.; Traina, T. A.; Robson, M. E.; Dang, C. T.
Abstract Title: Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120301091
DOI: 10.1200/JCO.2021.39.15_suppl.e15016
PROVIDER: wos
Notes: Meeting Abstract: e15016 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Mark E Robson
    585 Robson
  2. Chau Dang
    233 Dang
  3. Diana E Lake
    81 Lake
  4. Tiffany A Traina
    215 Traina
  5. Neil Mukund Iyengar
    106 Iyengar
  6. Rui Wang
    20 Wang
  7. Jasmeet Chadha Singh
    20 Singh
  8. Serena T Wong
    5 Wong
  9. Asta Kaba
    1 Kaba